Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel
Authors:
- Neal S. KleimanNKNeal S. Kleiman
- 1 January 2007
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 119 (3) , 355-360
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Glycoprotein IIIA Gene ( PIA ) Polymorphism and Aspirin Resistance: Is There Any Correlation?Annals of Pharmacotherapy, 2005
- Resistance to clopidogrel: A review of the evidenceJACC, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJACC, 2005
- Aspirin resistance: more than just a laboratory curiosity**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.JACC, 2004
- Resistance in vitro to low-dose aspirin is associated with platelet PlA1(GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphismsJACC, 2003
- Clopidogrel for Coronary StentingCirculation, 2003
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJACC, 2003
- Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placementThrombosis and Haemostasis, 2003
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIaBritish Journal of Haematology, 2000